Matt Wasserman

913 total citations
38 papers, 630 citations indexed

About

Matt Wasserman is a scholar working on Epidemiology, General Health Professions and Microbiology. According to data from OpenAlex, Matt Wasserman has authored 38 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 8 papers in General Health Professions and 8 papers in Microbiology. Recurrent topics in Matt Wasserman's work include Pneumonia and Respiratory Infections (33 papers), Respiratory viral infections research (23 papers) and Child and Adolescent Health (8 papers). Matt Wasserman is often cited by papers focused on Pneumonia and Respiratory Infections (33 papers), Respiratory viral infections research (23 papers) and Child and Adolescent Health (8 papers). Matt Wasserman collaborates with scholars based in United States, United Kingdom and Canada. Matt Wasserman's co-authors include Raymond Farkouh, Kim E. Barrett, Stephen B. Shears, Marco T. Rudolf, Andrew Craxton, Péter Enyedi, Alexis Traynor‐Kaplan, M. Vajanaphanich, Heather L. Sings and Carsten Schultz and has published in prestigious journals such as Nature, PLoS ONE and Emerging infectious diseases.

In The Last Decade

Matt Wasserman

36 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matt Wasserman United States 14 367 133 97 75 64 38 630
Carla M. Van Bennekom United States 10 95 0.3× 58 0.4× 43 0.4× 57 0.8× 31 0.5× 23 502
Hubert Huras Poland 15 185 0.5× 147 1.1× 25 0.3× 89 1.2× 42 0.7× 119 838
Margarida Tavares Portugal 10 112 0.3× 60 0.5× 6 0.1× 32 0.4× 50 0.8× 47 462
Ai Miyoshi Japan 10 122 0.3× 30 0.2× 18 0.2× 82 1.1× 33 0.5× 65 317
Kari S. Lankinen Finland 11 260 0.7× 39 0.3× 177 1.8× 16 0.2× 26 0.4× 15 619
Ravi Misra United Kingdom 8 121 0.3× 195 1.5× 40 0.4× 84 1.1× 33 0.5× 25 438
Ana María Cebrián Cuenca Spain 9 278 0.8× 85 0.6× 8 0.1× 64 0.9× 20 0.3× 36 587
Sara Renna Italy 17 449 1.2× 58 0.4× 3 0.0× 168 2.2× 13 0.2× 54 787
Sílvio OM Prietsch Brazil 9 139 0.4× 22 0.2× 122 1.3× 12 0.2× 217 3.4× 10 483
Vincenzo Pisani Italy 12 339 0.9× 37 0.3× 12 0.1× 33 0.4× 14 0.2× 25 650

Countries citing papers authored by Matt Wasserman

Since Specialization
Citations

This map shows the geographic impact of Matt Wasserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Wasserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Wasserman more than expected).

Fields of papers citing papers by Matt Wasserman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matt Wasserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Wasserman. The network helps show where Matt Wasserman may publish in the future.

Co-authorship network of co-authors of Matt Wasserman

This figure shows the co-authorship network connecting the top 25 collaborators of Matt Wasserman. A scholar is included among the top collaborators of Matt Wasserman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt Wasserman. Matt Wasserman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Lan, et al.. (2022). Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies. Value in Health. 26(4). 598–611. 17 indexed citations
2.
Huang, Liping, Matt Wasserman, Lindsay R. Grant, et al.. (2022). Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States. Vaccine. 40(33). 4700–4708. 32 indexed citations
3.
Wilson, Michele, Cheryl McDade, Johnna Perdrizet, et al.. (2021). Validation of a Novel Forecasting Method for Estimating the Impact of Switching Pneumococcal Conjugate Programs: Evidence from Belgium. Infectious Diseases and Therapy. 10(3). 1765–1778. 6 indexed citations
4.
5.
6.
Lapidot, Rotem, et al.. (2021). Community-acquired pneumonia in infants: Not simply an acute event with complete recovery. Respiratory Medicine. 191. 106671–106671.
7.
Sings, Heather L., Bradford D. Gessner, Matt Wasserman, & Luis Jódar. (2021). Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data. Infectious Diseases and Therapy. 10(1). 521–539. 23 indexed citations
8.
Perdrizet, Johnna, et al.. (2020). Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. Human Vaccines & Immunotherapeutics. 17(4). 1162–1172. 9 indexed citations
9.
Wasserman, Matt, et al.. (2020). PIN95 Public Health IMPACT of 10 YEARS of the 13 Valent Pneumococcal Vaccine in Africa and the Middle EAST in Children UNDER 5 YEARS. Value in Health. 23. S560–S560. 2 indexed citations
10.
Pugh, Sarah, Matt Wasserman, Mark H. Rozenbaum, et al.. (2020). Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis. Infectious Diseases and Therapy. 9(2). 305–324. 12 indexed citations
11.
Chapman, Ruth, et al.. (2020). Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Vaccine. 38(45). 7138–7145. 32 indexed citations
12.
Wilson, Michele, Matt Wasserman, Marie-Claude Breton, et al.. (2020). Health and Economic Impact of Routine Pediatric Pneumococcal Immunization Programs in Canada: A Retrospective Analysis. Infectious Diseases and Therapy. 9(2). 341–353. 11 indexed citations
13.
Wasserman, Matt, et al.. (2018). Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India. Value in Health Regional Issues. 15. 99–105. 4 indexed citations
14.
15.
Wasserman, Matt, A. O. Lucas, Dylan Jones, et al.. (2018). Dynamic transmission modelling to address infant pneumococcal conjugate vaccine schedule modifications in the UK. Epidemiology and Infection. 146(14). 1797–1806. 13 indexed citations
16.
Shen, Kunling, Matt Wasserman, Dongdong Liu, et al.. (2018). Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China. PLoS ONE. 13(7). e0201245–e0201245. 20 indexed citations
17.
Wilson, Michele, Matt Wasserman, Maarten J. Postma, et al.. (2018). Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada. Infectious Diseases and Therapy. 7(3). 353–371. 22 indexed citations
18.
Giudice, Pietro, et al.. (2015). Understanding the economic impact of intravascular ultrasound (IVUS). The European Journal of Health Economics. 17(2). 185–193. 55 indexed citations
19.
20.
Vajanaphanich, M., Carsten Schultz, Marco T. Rudolf, et al.. (1994). Long-term uncoupling of chloride secretion from intracellular calcium levels by lns(3,4,5,6)P4. Nature. 371(6499). 711–714. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla M. Van Bennekom Breakdown of academic impact, for papers by Hubert Huras Breakdown of academic impact, for papers by Margarida Tavares Breakdown of academic impact, for papers by Ai Miyoshi Breakdown of academic impact, for papers by Kari S. Lankinen Breakdown of academic impact, for papers by Ravi Misra Breakdown of academic impact, for papers by Ana María Cebrián Cuenca Breakdown of academic impact, for papers by Sara Renna Breakdown of academic impact, for papers by Sílvio OM Prietsch Breakdown of academic impact, for papers by Vincenzo Pisani
Rankless by CCL
2026